119 related articles for article (PubMed ID: 5048217)
1. Treatment of mycosis fungoides with topical nitrosourea compounds.
Zackheim HS
Arch Dermatol; 1972 Aug; 106(2):177-82. PubMed ID: 5048217
[No Abstract] [Full Text] [Related]
2. Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies.
Zackheim HS; Epstein EH
Arch Dermatol; 1975 Dec; 111(12):1564-70. PubMed ID: 1200661
[TBL] [Abstract][Full Text] [Related]
3. Topical lomustine in the treatment of psoriasis.
Peck GL; Guss SB; Key DJ
Arch Dermatol; 1972 Aug; 106(2):172-6. PubMed ID: 4558698
[No Abstract] [Full Text] [Related]
4. A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Res; 1972 Jun; 32(6):1278-9. PubMed ID: 4113144
[No Abstract] [Full Text] [Related]
5. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
Kinne DW; Humphrey EW
Cancer Chemother Rep; 1972 Feb; 56(1):53-9. PubMed ID: 5030809
[No Abstract] [Full Text] [Related]
6. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
[No Abstract] [Full Text] [Related]
7. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
Young RC; DeVita VT; Serpick AA; Canellos GP
N Engl J Med; 1971 Aug; 285(9):475-9. PubMed ID: 5558887
[No Abstract] [Full Text] [Related]
8. [Topical application of ACNU for the treatment of mycosis fungoides].
Jimbow K; Horikoshi T; Kamimura M
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1231-6. PubMed ID: 6964047
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the management of patients with advanced breast cancer.
Ahmann DL; Hahn RG; Bisel HF
Cancer Chemother Rep; 1972 Feb; 56(1):93-4. PubMed ID: 5030810
[No Abstract] [Full Text] [Related]
10. Topical carmustine (BCNU) for patch/plaque mycosis fungoides.
Zackheim HS
Semin Dermatol; 1994 Sep; 13(3):202-6. PubMed ID: 7986689
[TBL] [Abstract][Full Text] [Related]
11. The response of human lymphoma cells in vitro to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Drewinko B; Novak JK; Barranco SC
Cancer Res; 1972 Jun; 32(6):1206-8. PubMed ID: 4113143
[No Abstract] [Full Text] [Related]
12. Topical carmustine therapy for lymphomatoid papulosis.
Zackheim HS; Epstein EH; Crain WR
Arch Dermatol; 1985 Nov; 121(11):1410-4. PubMed ID: 4051529
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of bronchogenic carcinoma.
Olshin S; Siddiqui S; Firat D
Cancer Chemother Rep; 1972 Apr; 56(2):259-61. PubMed ID: 5043228
[No Abstract] [Full Text] [Related]
14. Treatment of malignant brain tumors with nitrosoureas.
Hansen HH; Muggia FM
Cancer Chemother Rep; 1971 Apr; 55(2):99-100. PubMed ID: 4330275
[No Abstract] [Full Text] [Related]
15. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
Mayo JG; Laster WR; Andrews CM; Schabel FM
Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
[No Abstract] [Full Text] [Related]
16. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
Wilson CB; Boldrey EB; Enot KJ
Cancer Chemother Rep; 1970 Aug; 54(4):273-81. PubMed ID: 4334089
[No Abstract] [Full Text] [Related]
17. Topical fluorouracil treatment of senile keratosis and mycosis fungoides. A clinical and ultrastructural study, with special reference to nucleolar structure.
Stenram U; Lidén S
Arch Geschwulstforsch; 1972; 39(2):153-62. PubMed ID: 4339665
[No Abstract] [Full Text] [Related]
18. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report.
Walker MD; Hurwitz BS
Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011
[No Abstract] [Full Text] [Related]
19. Structure-activity relationships: nitrosoureas.
Johnston TP
Cancer Chemother Rep 3; 1972 May; 3(1):50-1. PubMed ID: 5065660
[No Abstract] [Full Text] [Related]
20. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
van Eden EB; Falkson HC; Falkson G
Cancer Chemother Rep; 1970 Oct; 54(5):347-59. PubMed ID: 5514624
[No Abstract] [Full Text] [Related]
[Next] [New Search]